107 related articles for article (PubMed ID: 19013101)
1. Circadian variation of hypocretin-1 (orexin A) in restless legs syndrome.
Baier PC; Göder R; Hallschmid M
Sleep Med; 2009 Feb; 10(2):271; author reply 272. PubMed ID: 19013101
[No Abstract] [Full Text] [Related]
2. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
3. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome.
Allen RP; Mignot E; Ripley B; Nishino S; Earley CJ
Neurology; 2002 Aug; 59(4):639-41. PubMed ID: 12196669
[TBL] [Abstract][Full Text] [Related]
4. CSF hypocretin-1 levels in restless legs syndrome.
Stiasny-Kolster K; Mignot E; Ling L; Möller JC; Cassel W; Oertel WH
Neurology; 2003 Nov; 61(10):1426-9. PubMed ID: 14638970
[TBL] [Abstract][Full Text] [Related]
5. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.
Maeda T; Nagata K; Kondo H; Kanbayashi T
Sleep Med; 2006 Dec; 7(8):662. PubMed ID: 17097921
[No Abstract] [Full Text] [Related]
7. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
[TBL] [Abstract][Full Text] [Related]
8. On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy.
Mignot E; Chen W; Black J
Sleep; 2003 Sep; 26(6):646-9. PubMed ID: 14572113
[No Abstract] [Full Text] [Related]
9. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
[TBL] [Abstract][Full Text] [Related]
10. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
11. Kleine-Levin syndrome in a 14-year-old girl: CSF hypocretin-1 measurements.
Podestá C; Ferreras M; Mozzi M; Bassetti C; Dauvilliers Y; Billiard M
Sleep Med; 2006 Dec; 7(8):649-51. PubMed ID: 17098473
[TBL] [Abstract][Full Text] [Related]
12. Circadian variation in restless legs syndrome.
Baier PC; Trenkwalder C
Sleep Med; 2007 Sep; 8(6):645-50. PubMed ID: 17383937
[TBL] [Abstract][Full Text] [Related]
13. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
Rejdak K; Papuć E; Grieb P; Stelmasiak Z
Epilepsia; 2009 Jun; 50(6):1641-4. PubMed ID: 19175390
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
[TBL] [Abstract][Full Text] [Related]
15. CSF hypocretin-1 levels are normal in multiple-system atrophy.
Abdo WF; Bloem BR; Kremer HP; Lammers GJ; Verbeek MM; Overeem S
Parkinsonism Relat Disord; 2008; 14(4):342-4. PubMed ID: 17977056
[TBL] [Abstract][Full Text] [Related]
16. Does CSF hypocretin-1 decrease in Bickerstaff's brainstem encephalitis?
Saji N; Kawarai T; Tadano M; Shimizu H; Kita Y; Susuki K; Kanbayashi T
Clin Neurol Neurosurg; 2007 Jul; 109(6):547-8. PubMed ID: 17397994
[No Abstract] [Full Text] [Related]
17. [Orexin (ORX)].
Sakurai T
Nihon Rinsho; 2010 Jul; 68 Suppl 7():633-6. PubMed ID: 20963897
[No Abstract] [Full Text] [Related]
18. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment.
Dauvilliers Y; Abril B; Mas E; Michel F; Tafti M
Neurology; 2009 Oct; 73(16):1333-4. PubMed ID: 19841387
[No Abstract] [Full Text] [Related]
19. Circadian rhythms of basal orexin levels in the hypothalamus are not influenced by an impaired corticotropin-releasing hormone receptor type 1 system.
Fenzl T; Flachskamm C; Rossbauer M; Deussing JM; Kimura M
Behav Brain Res; 2009 Oct; 203(1):143-5. PubMed ID: 19379774
[TBL] [Abstract][Full Text] [Related]
20. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication overuse headache: findings from cerebrospinal fluid.
Holland PR; Bartsch T
Cephalalgia; 2008 Jul; 28(7):681-2. PubMed ID: 18479470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
